![Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management - The Lancet Respiratory Medicine Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7c764749-1dbd-4bd7-9067-412f1f280098/gr4_lrg.jpg)
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management - The Lancet Respiratory Medicine
![Severity and outcome of cystic lung disease in women with tuberous sclerosis complex | European Respiratory Society Severity and outcome of cystic lung disease in women with tuberous sclerosis complex | European Respiratory Society](https://erj.ersjournals.com/content/erj/45/1/171/F3.large.jpg)
Severity and outcome of cystic lung disease in women with tuberous sclerosis complex | European Respiratory Society
![The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis | Respiratory Research | Full Text The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-020-1316-3/MediaObjects/12931_2020_1316_Fig5_HTML.png)
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis | Respiratory Research | Full Text
![Breathing Easier: First Treatment for Rare Lung Disease Approved | National Center for Advancing Translational Sciences Breathing Easier: First Treatment for Rare Lung Disease Approved | National Center for Advancing Translational Sciences](https://ncats.nih.gov/files/lam-patient-hugging-her-daughter.jpg)
Breathing Easier: First Treatment for Rare Lung Disease Approved | National Center for Advancing Translational Sciences
![Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights](https://www.uchealth.com/wp-content/uploads/sites/39/2015/08/Frank-McCormack-Photo-for-Becca.jpg)
Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights
![Pulmonary Insights | University of Cincinnati Faculty Lead Development of LAM Guidelines | Pulmonary Insights Pulmonary Insights | University of Cincinnati Faculty Lead Development of LAM Guidelines | Pulmonary Insights](https://www.uchealth.com/wp-content/uploads/sites/39/2017/12/LAM-algorithm-408x280.png)